Lu-Wen Wang

1.5k total citations
48 papers, 916 citations indexed

About

Lu-Wen Wang is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Lu-Wen Wang has authored 48 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in Lu-Wen Wang's work include Liver Disease Diagnosis and Treatment (10 papers), Advanced Glycation End Products research (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). Lu-Wen Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Advanced Glycation End Products research (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). Lu-Wen Wang collaborates with scholars based in China, United States and Macao. Lu-Wen Wang's co-authors include Zuojiong Gong, Fan Yang, Fangzhou Jiao, Yao Wang, Wenbin Zhang, Haiyue Zhang, Xun Li, Hong Zhang, Likun Wang and Xun Li and has published in prestigious journals such as ACS Nano, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Lu-Wen Wang

45 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu-Wen Wang China 19 342 267 156 142 124 48 916
Philip Starkey Lewis United Kingdom 10 195 0.6× 188 0.7× 178 1.1× 293 2.1× 82 0.7× 13 740
Kwang Suk Ko South Korea 16 435 1.3× 175 0.7× 86 0.6× 65 0.5× 67 0.5× 47 1.0k
Wensong Ge China 12 374 1.1× 222 0.8× 91 0.6× 39 0.3× 171 1.4× 30 822
Céline Hernandez France 10 324 0.9× 450 1.7× 508 3.3× 95 0.7× 266 2.1× 13 1.2k
Adriaan Brouwer Netherlands 18 354 1.0× 218 0.8× 200 1.3× 72 0.5× 118 1.0× 26 862
Pujun Gao China 19 298 0.9× 355 1.3× 225 1.4× 48 0.3× 138 1.1× 54 995
Harri A. Järveläinen Finland 16 265 0.8× 436 1.6× 127 0.8× 96 0.7× 115 0.9× 25 941
Suzanne Duijst Netherlands 16 374 1.1× 238 0.9× 124 0.8× 37 0.3× 67 0.5× 33 1.1k

Countries citing papers authored by Lu-Wen Wang

Since Specialization
Citations

This map shows the geographic impact of Lu-Wen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu-Wen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu-Wen Wang more than expected).

Fields of papers citing papers by Lu-Wen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu-Wen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu-Wen Wang. The network helps show where Lu-Wen Wang may publish in the future.

Co-authorship network of co-authors of Lu-Wen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lu-Wen Wang. A scholar is included among the top collaborators of Lu-Wen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu-Wen Wang. Lu-Wen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jing, Wenyuan Yu, Guoqiang Li, et al.. (2025). Robust and Regular Micronano Binary Texture on the Complex Curved Surface for Enhanced Reendothelialization and Antithrombotic Performance. ACS Nano. 19(3). 3676–3693. 2 indexed citations
2.
Zhang, Caili, et al.. (2025). ALKBH1 knockdown promotes the growth, migration and invasion of HTR-8/SVneo cells through regulating the m5C modification PSMD14. Scientific Reports. 15(1). 7345–7345. 4 indexed citations
3.
4.
Li, Wenyuan, Lu-Wen Wang, Jin Dong, & Yao Wang. (2024). Evaluation of G3BP1 in the prognosis of acute and acute-on-chronic liver failure after the treatment of artificial liver support system. World Journal of Hepatology. 16(2). 251–263.
5.
Zhang, Qingqi, Qian Chen, Pan Cao, et al.. (2023). AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway. Hepatobiliary & pancreatic diseases international. 23(1). 43–51. 8 indexed citations
6.
Zhang, Yanqiong, Chunxia Shi, Danmei Zhang, et al.. (2023). Sulforaphane, an NRF2 agonist, alleviates ferroptosis in acute liver failure by regulating HDAC6 activity. Journal of Integrative Medicine. 21(5). 464–473. 17 indexed citations
7.
Li, Wenyuan, Fan Yang, Xun� Li, Lu-Wen Wang, & Yao Wang. (2023). Stress granules inhibit endoplasmic reticulum stress-mediated apoptosis during hypoxia-induced injury in acute liver failure. World Journal of Gastroenterology. 29(8). 1315–1329. 16 indexed citations
8.
Li, Wenyuan, et al.. (2023). Effect of P53 nuclear localization mediated by G3BP1 on ferroptosis in acute liver failure. APOPTOSIS. 28(7-8). 1226–1240. 10 indexed citations
9.
10.
Cao, Pan, Qian Chen, Chunxia Shi, Lu-Wen Wang, & Zuojiong Gong. (2022). Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α. World Journal of Gastroenterology. 28(17). 1798–1813. 7 indexed citations
11.
Shi, Chunxia, Yao Wang, Fangzhou Jiao, et al.. (2021). Epigenetic Regulation of Hepatic Stellate Cell Activation and Macrophage in Chronic Liver Inflammation. Frontiers in Physiology. 12. 683526–683526. 8 indexed citations
12.
Chen, Hui, Yao Wang, Fangzhou Jiao, et al.. (2020). <p>Sinomenine Attenuates Acetaminophen-Induced Acute Liver Injury by Decreasing Oxidative Stress and Inflammatory Response via Regulating TGF-β/Smad Pathway in vitro and in vivo</p>. Drug Design Development and Therapy. Volume 14. 2393–2403. 37 indexed citations
13.
Jiao, Fangzhou, Yao Wang, Wenbin Zhang, et al.. (2019). Protective role of AGK2 on thioacetamide-induced acute liver failure in mice. Life Sciences. 230. 68–75. 21 indexed citations
14.
Zhang, Wenbin, Haiyue Zhang, Yao Wang, et al.. (2019). Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice. Frontiers in Pharmacology. 10. 653–653. 11 indexed citations
15.
Zhang, Di, Yao Wang, Haiyue Zhang, et al.. (2019). Histone deacetylases and acetylated histone H3 are involved in the process of hepatitis B virus DNA replication. Life Sciences. 223. 1–8. 14 indexed citations
16.
Jiao, Fangzhou, Yao Wang, Haiyue Zhang, et al.. (2018). Histone Deacetylase 2 Inhibitor CAY10683 Alleviates Lipopolysaccharide Induced Neuroinflammation Through Attenuating TLR4/NF-κB Signaling Pathway. Neurochemical Research. 43(6). 1161–1170. 28 indexed citations
17.
Zhang, Qian, Fan Yang, Xun Li, et al.. (2016). Trichostatin A protects against intestinal injury in rats with acute liver failure. Journal of Surgical Research. 205(1). 1–10. 14 indexed citations
18.
Wang, Likun, et al.. (2013). Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure. Hepatobiliary & pancreatic diseases international. 12(2). 180–188. 34 indexed citations
19.
Zhang, Wei, Lu-Wen Wang, Xun Li, et al.. (2013). Betaine Protects Against High-Fat-Diet-Induced Liver Injury by Inhibition of High-Mobility Group Box 1 and Toll-Like Receptor 4 Expression in Rats. Digestive Diseases and Sciences. 58(11). 3198–3206. 89 indexed citations
20.
Wang, Lu-Wen. (2006). Effects of Betaine on hyperhomocysteinemia and lipid peroxidation rats with ethanol-induced liver injury. Chinese journal of integrated traditional and Western medicine. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Starkey Lewis Breakdown of academic impact, for papers by Kwang Suk Ko Breakdown of academic impact, for papers by Wensong Ge Breakdown of academic impact, for papers by Céline Hernandez Breakdown of academic impact, for papers by Adriaan Brouwer Breakdown of academic impact, for papers by Pujun Gao Breakdown of academic impact, for papers by Harri A. Järveläinen Breakdown of academic impact, for papers by Suzanne Duijst
Rankless by CCL
2026